NUTLEY, N.J., May 4 Roche Public Affairs Director Stacy Quinn of Belleville, N.J., will be honored as a 2010 Rising Star by the Healthcare Businesswomen's Association (HBA) at the organization's annual awards luncheon on May 6, 2010 in New York City.
"Stacy is dedicated to her craft, has an eye for detail and has earned the appreciation and respect of the management team, her peers and other colleagues within and outside the company. She demonstrates the values, professionalism and emerging leadership skills that will lead to a long and very successful career in health care," Al Wasilewski, Roche executive director, Public Affairs.
"We are extremely proud of Stacy. She is very deserving of this prestigious award, the epitome of a rising star. She is an inspiration to those around her and contributes in many ways to the continued success of our company," added Ivor Macleod, President of the Roche Nutley Site.
The HBA, based in Fairfield, NJ (www.hbanet.org), is a national not-for-profit organization dedicated to furthering the advancement of women in the pharmaceutical and healthcare industries. Its Rising Star Award recognizes women whose outstanding accomplishments make a difference in the industry.
Quinn, who joined Roche in 2005 as a communications specialist and held increasingly responsible positions before being named Public Affairs director for Internal Communications in 2008, was instrumental in designing and implementing a comprehensive employee communications program for the 2009 Roche-Genentech merger that was recently lauded with a top award from the NJ Chapter of the International Association of Business Communications (IABC). She works closely with senior leaders, scientists and other key groups at Roche to develop and deliver internal communications programs that support business goals. From a weekly e-newsletter to management presentations, Quinn oversees the development, approval and distribution of internal messages, and is committed to fostering an environment of open, transparent communications.
Quinn came to Roche from American International Group (AIG), and also worked at Cendant Corporation and Casino Journal Publishing Group. She earned a B.A. in Communications, magna cum laude, from Rowan University, Glassboro, N.J.
The Rising Star recognition, she said, adds fuel to her passion for work. "Someone who is very close to me was diagnosed with breast cancer in 2008. It was devastating. I am very proud to work for a company that is dedicated to combat this and so many other diseases," she said. "In my job, I get to collaborate with all of the functions and departments on the Nutley campus, so I also feel very lucky to have the opportunity to work with such a wonderful, talented group of professionals."
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2009, Roche had over 80,000 employees worldwide and invested almost 10 billion Swiss francs in R&D ($9.1B US). The Group posted sales of 49.1 billion Swiss francs ($45.1B US). Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche.com or www.roche-nutley.com.